eCTD FAQs

What is the eCTD?

The Electronic Common Technical Document (eCTD) is a globally accepted standard for organizing the content of regulatory submissions in an electronic format, primarily used in the pharmaceutical industry for regulatory submissions.

 

What are the components of an eCTD submission?

An eCTD submission consists of five modules: Module 1 (regional information), Module 2 (summaries), Module 3 (quality), Module 4 (nonclinical study reports), and Module 5 (clinical study reports).

 

Which regulatory authorities accept eCTD submissions?

Major regulatory authorities like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others in regions like Canada, Japan, and Australia accept eCTD submissions.

 

How does eCTD ensure data integrity and security?

The eCTD format uses checksums and digital signatures to ensure data integrity.

 

What software is needed to create an eCTD submission?

Specialized software is required to compile and validate an eCTD submission to ensure it meets the specific technical standards set by regulatory authorities. There are multiple vendors in the marketplace who sell eCTD management and viewing tools.

 

How does eCTD differ from paper-based submissions?

eCTD submissions are more structured and efficient compared to paper-based submissions. They allow for easier navigation, quicker review times, and more efficient update and amendment processes.

 

What are the challenges associated with eCTD submissions?

Challenges include managing the large volume of data, ensuring compliance with varying regional requirements, and keeping up with changing regulatory standards.

 

Can eCTD submissions be updated or amended?

Yes, eCTD submissions can be updated or amended. The format allows for incremental updates, where only the changed or new information is submitted.

 

How do you send an eCTD to the FDA?

The FDA uses an electronic submission gateway to receive eCTD submissions. You can learn how to use it on the agency website.

 

Are there different versions of the eCTD format?

Yes, there are different versions of the eCTD format. Regulatory authorities periodically update the specifications to incorporate new technical and regulatory requirements. Regulatory teams need to stay informed about the current version required by each regulatory authority.

 

Where can I learn about the data standards and terminologies the FDA currently supports for submissions?

The agency publishes a Data Standards Catalog that lists the data standards and terminologies that FDA supports for use in regulatory submissions. You can access it here. The FDA also has an eCTD Resource page that lists relevant guidances, submission standards, validation specifications, and more! You can access it here.

 

How does eCTD support post-approval changes and reporting?

The eCTD format is designed to support lifecycle management, allowing for the submission of post-approval changes, annual reports, and other lifecycle management documentation in a structured and efficient manner.

 

Is training required for staff preparing eCTD submissions?

Yes, training is typically required for staff involved in preparing eCTD submissions. Understanding the technical requirements, software tools, and regulatory guidelines is crucial for successful submission.

 

How does eCTD facilitate international regulatory submissions?

The eCTD format, being a standard across multiple regulatory regions, simplifies the process of submitting the same documentation to different regulatory bodies. It helps in maintaining consistency and efficiency in international submissions.

 

Can eCTD submissions be reused for different regulatory authorities?

Yes, the core components of an eCTD submission (Modules 2-5) can often be reused across different regulatory authorities. However, Module 1 is specific to each region and must be tailored accordingly.

 

What are common mistakes to avoid in eCTD submissions?

Common mistakes include non-compliance with specific regional guidelines, incorrect formatting, missing documents or data, and errors in hyperlinks and bookmarks within the submission.

 

How has the adoption of eCTD benefited the pharmaceutical industry?

The adoption of eCTD has streamlined the regulatory submission process, reduced review times, and improved communication between regulatory authorities and pharmaceutical companies.

​

​